Novartis explains stance over India patent law challenge

Article Date: 27/02/2012 08:00
Novartis explains stance over India patent law challenge

Vacancy Search

Quick job search

Advanced Search

Latest News

US OKs first jab for Meningitis B

US OKs first jab for Meningitis B

Abbott buys into fizzing electrophysiology sector

Expansion of the overall medical device market has slowed in recent years, but among the areas defying this trend electrophysiology stands out, with forecast growth of 10% to 2020.

Sanofi’s premium price hands Novo insulin win

The hole blown in Sanofi’s profit outlook from the loss of Lantus sales makes a little more sense in the context of its US pricing strategy against its only rival, Novo Nordisk’s Levemir.

The biomedical revolution has begun

The biomedical revolution has begun

Sanofi sacks chief executive Viehbacher

Sanofi sacks chief executive Viehbacher

Cancer Drugs Fund 'is papering over the cracks,' say campaigners

Cancer Drugs Fund 'is papering over the cracks,' say campaigners

Health screenings: MPs slam poor communication

Health screenings: MPs slam poor communication

£100m for GPs to extend opening hours and access

£100m for GPs to extend opening hours and access

Poor industry scorecard drives desmoteplase rescue plan

Analysts had written off the stroke project desmoteplase after its failure in the phase III Dias-3 trial in June, but you can hardly blame its owner, Lundbeck, for trying to find a way...

Asia-Pacifc J&J Innovation Center opens with Shanghai HQ

Asia-Pacifc J&J Innovation Center opens with Shanghai HQ
more news